LYAR promotes colorectal cancer cell mobility by activating galectin-1 expression.
about
Multivariate models from RNA-Seq SNVs yield candidate molecular targets for biomarker discovery: SNV-DALung cancer-derived galectin-1 contributes to cancer associated fibroblast-mediated cancer progression and immune suppression through TDO2/kynurenine axis.Expression of miRNA-26b-5p and its target TRPS1 is associated with radiation exposure in post-Chernobyl breast cancer.MEG3 Activated by Vitamin D Inhibits Colorectal Cancer Cells Proliferation and Migration via Regulating Clusterin.
P2860
LYAR promotes colorectal cancer cell mobility by activating galectin-1 expression.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
LYAR promotes colorectal cancer cell mobility by activating galectin-1 expression.
@ast
LYAR promotes colorectal cancer cell mobility by activating galectin-1 expression.
@en
type
label
LYAR promotes colorectal cancer cell mobility by activating galectin-1 expression.
@ast
LYAR promotes colorectal cancer cell mobility by activating galectin-1 expression.
@en
prefLabel
LYAR promotes colorectal cancer cell mobility by activating galectin-1 expression.
@ast
LYAR promotes colorectal cancer cell mobility by activating galectin-1 expression.
@en
P2093
P2860
P356
P1433
P1476
LYAR promotes colorectal cancer cell mobility by activating galectin-1 expression.
@en
P2093
Chen-Yu Zhang
Feifei Huang
Ming-Rong Wang
P2860
P304
32890-32901
P356
10.18632/ONCOTARGET.5335
P407
P577
2015-09-25T00:00:00Z